Search research articles
Contact Us
Filters
Showing results (21-30 of 44) with videos related to
Page
of 5
Sort By:
Epilepsia
|
September 1, 1985
Relative bioavailability of rectally administered carbamazepine suspension in humans
N M Graves, R L Kriel, C Jones-Saete, et al.
Clinical Pharmacology and Therapeutics
|
July 1, 1997
A randomized double-blind study of carbamazepine in the treatment of cocaine abuse
J A Halikas, R D Crosby, V L Pearson, et al.
Neurology
|
January 1, 1995
Involuntary movement disorders associated with felbamate
J M Kerrick, B J Kelley, B H Maister, et al.
Epilepsia
|
November 1, 1987
Quantitative determination of phenytoin and phenobarbital in capillary blood by Ames Seralyzer
N M Graves, G B Holmes, I E Leppik, et al.
Clinical Neuropharmacology
|
December 1, 1987
Effect of progabide on serum phenytoin and carbamazepine concentrations
R C Brundage, J C Cloyd, I E Leppik, et al.
Pharmacotherapy
|
January 1, 1989
Pharmacokinetics of felbamate, a novel antiepileptic drug: application of mixed-effect modeling to clinical trials
N M Graves, T M Ludden, G B Holmes, et al.
DICP : the Annals of Pharmacotherapy
|
July 1, 1989
Relative bioavailability of rectally administered phenobarbital sodium parenteral solution
N M Graves, G B Holmes, R L Kriel, et al.
Clinical Pharmacology and Therapeutics
|
July 1, 1991
Cocaine reduction in unmotivated crack users using carbamazepine versus placebo in a short-term, double-blind crossover design
J A Halikas, R D Crosby, G A Carlson, et al.
Epilepsia
|
May 1, 1991
Discontinuation of phenytoin and carbamazepine in patients receiving felbamate
M L Wagner, N M Graves, K Marienau, et al.
Archives of Neurology
|
August 1, 1989
Absorption of valproic acid suppositories in human volunteers
G B Holmes, W E Rosenfeld, N M Graves, et al.
Page
of 5
Search research articles
Search
Showing results (21-30 of 44) with videos related to
Sort By:
Page
of 5
Epilepsia
|
September 1, 1985
Relative bioavailability of rectally administered carbamazepine suspension in humans
N M Graves, R L Kriel, C Jones-Saete, et al.
Clinical Pharmacology and Therapeutics
|
July 1, 1997
A randomized double-blind study of carbamazepine in the treatment of cocaine abuse
J A Halikas, R D Crosby, V L Pearson, et al.
Neurology
|
January 1, 1995
Involuntary movement disorders associated with felbamate
J M Kerrick, B J Kelley, B H Maister, et al.
Epilepsia
|
November 1, 1987
Quantitative determination of phenytoin and phenobarbital in capillary blood by Ames Seralyzer
N M Graves, G B Holmes, I E Leppik, et al.
Clinical Neuropharmacology
|
December 1, 1987
Effect of progabide on serum phenytoin and carbamazepine concentrations
R C Brundage, J C Cloyd, I E Leppik, et al.
Pharmacotherapy
|
January 1, 1989
Pharmacokinetics of felbamate, a novel antiepileptic drug: application of mixed-effect modeling to clinical trials
N M Graves, T M Ludden, G B Holmes, et al.
DICP : the Annals of Pharmacotherapy
|
July 1, 1989
Relative bioavailability of rectally administered phenobarbital sodium parenteral solution
N M Graves, G B Holmes, R L Kriel, et al.
Clinical Pharmacology and Therapeutics
|
July 1, 1991
Cocaine reduction in unmotivated crack users using carbamazepine versus placebo in a short-term, double-blind crossover design
J A Halikas, R D Crosby, G A Carlson, et al.
Epilepsia
|
May 1, 1991
Discontinuation of phenytoin and carbamazepine in patients receiving felbamate
M L Wagner, N M Graves, K Marienau, et al.
Archives of Neurology
|
August 1, 1989
Absorption of valproic acid suppositories in human volunteers
G B Holmes, W E Rosenfeld, N M Graves, et al.
Page
of 5